Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9(1):77–93

Article  PubMed  Google Scholar 

Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347–361

Article  PubMed  PubMed Central  Google Scholar 

Li X, Zhao L, Zhou S, Hu C, Shi Y, Shi W, Li H, Liu F, Wu B, Wang Y (2015) A comprehensive database of Duchenne and Becker muscular dystrophy patients (0–18 years old) in East China. Orphanet J Rare Dis 10:5

Article  PubMed  PubMed Central  Google Scholar 

Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Rev Dis Primers 7(1):13

Article  PubMed  PubMed Central  Google Scholar 

McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation 131(18):1590–8

Article  PubMed  PubMed Central  Google Scholar 

Van Ruiten HJ, Marini Bettolo C, Cheetham T, Eagle M, Lochmuller H, Straub V, Bushby K, Guglieri M (2016) Why are some patients with Duchenne muscular dystrophy dying young: An analysis of causes of death in North East England. Eur J Paedia Neurol : EJPN : Off J Eur Paedia Neurol Soc 20(6):904–909

Article  Google Scholar 

Wittlieb-Weber CA, Knecht KR, Villa CR, Cunningham C, Conway J, Bock MJ, Gambetta KE, Lal AK, Schumacher KR, Law SP, Deshpande SR, West SC, Friedland-Little JM, Lytrivi ID, McCulloch MA, Butts RJ, Weber DR, Johnson JN (2020) Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy. Pediatr Cardiol 41(4):764–771

Article  PubMed  PubMed Central  Google Scholar 

Miyatake S, Shimizu-Motohashi Y, Takeda S, Aoki Y (2016) Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors. Drug Des Dev Ther 10:2745–2758

Article  CAS  Google Scholar 

Kourakis S, Timpani CA, Campelj DG, Hafner P, Gueven N, Fischer D, Rybalka E (2021) Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? Orphanet J Rare Dis 16(1):117

Article  PubMed  PubMed Central  Google Scholar 

Łoboda A, Dulak J (2020) Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future. Pharmacol Rep : PR 72(5):1227–1263

Article  PubMed  Google Scholar 

Quattrocelli M, Zelikovich AS, Salamone IM, Fischer JA, McNally EM (2021) Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy. J Neuromusc Dis 8(1):39–52

Article  Google Scholar 

Escolar DM, Hache LP, Clemens PR, Cnaan A, McDonald CM, Viswanathan V, Kornberg AJ, Bertorini TE, Nevo Y, Lotze T, Pestronk A, Ryan MM, Monasterio E, Day JW, Zimmerman A, Arrieta A, Henricson E, Mayhew J, Florence J, Hu F, Connolly AM (2011) Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy. Neurology 77(5):444–452

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fenichel GM, Florence JM, Pestronk A, Mendell JR, Moxley RT 3rd, Griggs RC, Brooke MH, Miller JP, Robison J, King W et al (1991) Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology 41(12):1874–1877

Article  CAS  PubMed  Google Scholar 

Matthews DJ, James KA, Miller LA, Pandya S, Campbell KA, Ciafaloni E, Mathews KD, Miller TM, Cunniff C, Meaney FJ, Druschel CM, Romitti PA, Fox DJ (2010) Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy. J Child Neurol 25(11):1319–1324

Article  PubMed  PubMed Central  Google Scholar 

Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY (2016) Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev 2016(5):Cd003725

PubMed  PubMed Central  Google Scholar 

Moxley RT 3rd, Pandya S, Ciafaloni E, Fox DJ, Campbell K (2010) Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol 25(9):1116–1129

Article  PubMed  Google Scholar 

Varga L, Fenner K, Singer H, Honti M (2023) From market to environment - consumption-normalised pharmaceutical emissions in the Rhine catchment. Water Res 239:120017

Article  CAS  PubMed  Google Scholar 

Wong BL, Rybalsky I, Shellenbarger KC, Tian C, McMahon MA, Rutter MM, Sawnani H, Jefferies JL (2017) Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment. J Pediatr 182:296-303.e1

Article  CAS  PubMed  Google Scholar 

Silversides CK, Webb GD, Harris VA, Biggar DW (2003) Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy. Am J Cardiol 91(6):769–772

Article  CAS  PubMed  Google Scholar 

Biggar WD, Harris VA, Eliasoph L, Alman B (2006) Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromusc Disord : NMD 16(4):249–255

Article  CAS  PubMed  Google Scholar 

Houde S, Filiatrault M, Fournier A, Dubé J, D’Arcy S, Bérubé D, Brousseau Y, Lapierre G, Vanasse M (2008) Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 38(3):200–206

Article  PubMed  Google Scholar 

Mavrogeni S, Papavasiliou A, Douskou M, Kolovou G, Papadopoulou E, Cokkinos DV (2009) Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study. Eur J Paedia Neurol : EJPN : Off J Eur Paedia Neurol Soc 13(1):34–40

Article  Google Scholar 

Markham LW, Kinnett K, Wong BL, Woodrow Benson D, Cripe LH (2008) Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromusc dis : NMD 18(5):365–370

Article  PubMed  Google Scholar 

Barber BJ, Andrews JG, Lu Z, West NA, Meaney FJ, Price ET, Gray A, Sheehan DW, Pandya S, Yang M, Cunniff C (2013) Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy. J Pediatr 163(4):1080–4.e1

Article  CAS  PubMed  Google Scholar 

Schram G, Fournier A, Leduc H, Dahdah N, Therien J, Vanasse M, Khairy P (2013) All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol 61(9):948–954

Article  PubMed  Google Scholar 

Zhang L, Liu Z, Hu KY, Tian QB, Wei LG, Zhao Z, Shen HR, Hu J (2015) Early myocardial damage assessment in dystrophinopathies using (99)Tc(m)-MIBI gated myocardial perfusion imaging. Ther Clin Risk Manag 11:1819–1827

CAS  PubMed  PubMed Central  Google Scholar 

Tandon A, Villa CR, Hor KN et al (2015) Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy. J Am Heart Assoc 4(4):e001338. https://doi.org/10.1161/JAHA.114.001338

Kirchmann C, Kececioglu D, Korinthenberg R, Dittrich S (2005) Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr Cardiol 26(1):66–72

Article  CAS  PubMed  Google Scholar 

Spurney C, Shimizu R, Morgenroth LP, Kolski H, Gordish-Dressman H, Clemens PR (2014) Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50(2):250–256

Article  PubMed  PubMed Central  Google Scholar 

Kim S, Zhu Y, Romitti PA, Fox DJ, Sheehan DW, Valdez R, Matthews D, Barber BJ (2017) Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy. Neuromusc Dis : NMD 27(8):730–737

Article  PubMed  Google Scholar 

Hussein G, Mansour L, Ghafar HA, Mostafa FA, Fawaz L (2014) Short-term effects of corticosteroid therapy on cardiac and skeletal muscles in muscular dystrophies. J Investig Med Off Publ Am Federat Clin Res 62(6):875–879

CAS  Google Scholar